BACKGROUND: Carbonic anhydrase IX (MN/Ca9) catalyses the reversible metabolism of carbon dioxide to carbonic acid and has also been linked to malignant transformation and hypoxia in various cancers. AIMS: To assess the expression and biological role of Ca9 in gastric cancer. METHODS: Using gastric cancer cell lines and tissues, we studied expression of Ca9 by western blot analysis, immunohistochemistry, and polymerase chain reaction. Biological changes after Ca9 transfection and after treatment with 5'-azadeoxycytidine were also analysed in cancer cell lines. RESULTS: Non-cancerous tissues strongly expressed Ca9 with membranous localisation. In contrast, Ca9 expression was frequently lost in gastric cancers (p<0.001). However, gastric cancers that retained Ca9 expression in cancer cells exhibited a shorter postoperative survival (p = 0.028). In vitro analysis revealed that loss of Ca9 expression in gastric cancer cell lines was restored after treatment with 5'-azadeoxycytidine and was associated with increased invasion (p<0.01). Moreover, AGS cells transfected with Ca9 exhibited significantly increased cell proliferation (p<0.05). CONCLUSIONS: A subgroup of gastric cancers retain Ca9 expression in cancer cells at the invasion front. While loss of Ca9 expression is regulated in part by methylation, re-expression of Ca9 is associated with increased invasion, supporting the hypothesis that increased Ca9 expression may contribute to invasion and thus advanced disease and tumour progression in a subset of gastric cancers.
BACKGROUND:Carbonic anhydrase IX (MN/Ca9) catalyses the reversible metabolism of carbon dioxide to carbonic acid and has also been linked to malignant transformation and hypoxia in various cancers. AIMS: To assess the expression and biological role of Ca9 in gastric cancer. METHODS: Using gastric cancer cell lines and tissues, we studied expression of Ca9 by western blot analysis, immunohistochemistry, and polymerase chain reaction. Biological changes after Ca9 transfection and after treatment with 5'-azadeoxycytidine were also analysed in cancer cell lines. RESULTS:Non-cancerous tissues strongly expressed Ca9 with membranous localisation. In contrast, Ca9 expression was frequently lost in gastric cancers (p<0.001). However, gastric cancers that retained Ca9 expression in cancer cells exhibited a shorter postoperative survival (p = 0.028). In vitro analysis revealed that loss of Ca9 expression in gastric cancer cell lines was restored after treatment with 5'-azadeoxycytidine and was associated with increased invasion (p<0.01). Moreover, AGS cells transfected with Ca9 exhibited significantly increased cell proliferation (p<0.05). CONCLUSIONS: A subgroup of gastric cancers retain Ca9 expression in cancer cells at the invasion front. While loss of Ca9 expression is regulated in part by methylation, re-expression of Ca9 is associated with increased invasion, supporting the hypothesis that increased Ca9 expression may contribute to invasion and thus advanced disease and tumour progression in a subset of gastric cancers.
Authors: S Pastoreková; S Parkkila; A K Parkkila; R Opavský; V Zelník; J Saarnio; J Pastorek Journal: Gastroenterology Date: 1997-02 Impact factor: 22.682
Authors: R Opavský; S Pastoreková; V Zelník; A Gibadulinová; E J Stanbridge; J Závada; R Kettmann; J Pastorek Journal: Genomics Date: 1996-05-01 Impact factor: 5.736
Authors: S Y Liao; C Brewer; J Závada; J Pastorek; S Pastorekova; A Manetta; M L Berman; P J DiSaia; E J Stanbridge Journal: Am J Pathol Date: 1994-09 Impact factor: 4.307
Authors: J Pastorek; S Pastoreková; I Callebaut; J P Mornon; V Zelník; R Opavský; M Zat'ovicová; S Liao; D Portetelle; E J Stanbridge Journal: Oncogene Date: 1994-10 Impact factor: 9.867
Authors: G Stemmermann; S C Heffelfinger; A Noffsinger; Y Z Hui; M A Miller; C M Fenoglio-Preiser Journal: Hum Pathol Date: 1994-10 Impact factor: 3.466
Authors: M Juhász; J Chen; U Lendeckel; U Kellner; H-U Kasper; Z Tulassay; S Pastorekova; P Malfertheiner; M P A Ebert Journal: Aliment Pharmacol Ther Date: 2003-10-15 Impact factor: 8.171
Authors: J Saarnio; S Parkkila; A K Parkkila; K Haukipuro; S Pastoreková; J Pastorek; M I Kairaluoma; T J Karttunen Journal: Am J Pathol Date: 1998-07 Impact factor: 4.307
Authors: Minna Nortunen; Heikki Huhta; Olli Helminen; Seppo Parkkila; Joonas H Kauppila; Tuomo J Karttunen; Juha Saarnio Journal: Virchows Arch Date: 2018-07-31 Impact factor: 4.064
Authors: Helen M Ameis; Astrid Drenckhan; Morton Freytag; Jakob R Izbicki; Claudiu T Supuran; Konrad Reinshagen; Stefan Holland-Cunz; Stephanie J Gros Journal: Pediatr Surg Int Date: 2015-10-28 Impact factor: 1.827
Authors: Jenghwa Chang; Bixiu Wen; Peter Kazanzides; Pat Zanzonico; Ronald D Finn; Gabor Fichtinger; C Clifton Ling Journal: Med Phys Date: 2009-11 Impact factor: 4.071
Authors: Guorong Li; Gang Feng; Anne Gentil-Perret; Christian Genin; Jacques Tostain Journal: Clin Exp Metastasis Date: 2007-03-28 Impact factor: 5.150